Guidelines for the diagnosis of antibody-mediated rejection in pancreas allografts-updated Banff grading schema

American Journal of Transplantation

Volumn 11, Issue 9, 2011, Pages 1792-1802

  Drachenberg, Cinthia B ^a   Torrealba, J R ^b   Nankivell, B J ^c   Rangel, E B ^d   Bajema, I M ^e   Kim, D U ^f   Arend, L ^g   Bracamonte, E R ^h   Bromberg, J S ^a   Bruijn, J A ^e   Cantarovich, D ⁱ   Chapman, J R ^c   Farris, A B ^j   Gaber, L ^k   Goldberg, J C ^l   Haririan, A ^a   Honsova E ^m   Iskandar, S S ⁿ   Klassen, D K ^a   Kraus, E ^g   Lower, F ^o   Odorico, J ^b   Olson, J L ^p   Mittalhenkle, A ^q   Munivenkatappa, R ^a   Paraskevas, S ^r,s   Papadimitriou, J C ^a   Randhawa, P ^t   Reinholt, F P ^u,v   Renaudin, K ⁱ   Revelo, P ^w   Ruiz, P ^x   Samaniego, M D ^y   Shapiro, R ^s   Stratta, R J ⁿ   Sutherland, D E R ^z   Troxell, M L ^p   Voska, L ^m   Seshan, S V ^aa   Racusen, L C ^g   Bartlett, S T ^a   more..

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF SYDNEY   (Australia)

^d HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f SAINT BARNABAS MEDICAL CENTER   (United States)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

ⁱ HÔTEL DIEU   (France)

^j EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k HOUSTON METHODIST HOSPITAL   (United States)

^l Instituto de Nefrologia Buenos Aires ar   (Argentina)

^m INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

ⁿ WAKE FOREST SCHOOL OF MEDICINE   (United States)

^o SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^p UNIVERSITY OF CALIFORNIA   (United States)

^q OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^r OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^s MCGILL UNIVERSITY   (Canada)

^t UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^u UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^v UNIVERSITY OF OSLO   (Norway)

^w UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^x UNIVERSITY OF MIAMI   (United States)

^y UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^z UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^aa WEILL CORNELL MEDICAL COLLEGE   (United States)

more..

Author keywords

Acinar cell injury; active chronic antibody mediated rejection; amylin; amyloid; C4d; cell mediated rejection; donor specific antibody; interacinar capillaries; pancreas biopsy; transplant arteriopathy

Indexed keywords

COMPLEMENT COMPONENT C4D;

ACUTE T CELL MEDIATED REJECTION; ANTIBODY MEDIATED REJECTION; ARTICLE; CHRONIC GRAFT REJECTION; CLINICAL FEATURE; GRAFT FAILURE; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; HYPERACUTE GRAFT REJECTION; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; RATING SCALE;

AUTOANTIBODIES; GRAFT REJECTION; HUMANS; PANCREAS TRANSPLANTATION; PRACTICE GUIDELINES AS TOPIC;

EID: 80052265100     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03670.x     Document Type: Article

References (70)

1. Gruessner AC, Sutherland DE, Gruessner RW,. Pancreas transplantation in the United States: A review. Curr Opin Organ Transplant 2010; 15: 93-101.
2. Drachenberg CB, Papadimitriou JC, Farney A, et al,. Pancreas transplantation: The histologic morphology of graft loss and clinical correlations. Transplantation 2001; 71: 1784-1791. (Pubitemid 32622491)
3. Luan FL, Trillsch F, Henger A, et al,. A pilot study of gene expression-based categorization of pancreas transplant biopsies. Transplantation 2009; 87: 222-226.
4. Nakhleh RE, Sutherland DE,. Biopsies from pancreas allografts at time of dysfunction: Pathologic comparison of allografts which ultimately failed versus those which continued to function. Transplant Proc 1993; 25 (1 Pt 2): 1194-1195. (Pubitemid 23078950)
5. Papadimitriou JC, Drachenberg CB, Klassen DK, et al,. Histological grading of chronic pancreas allograft rejection/graft sclerosis. Am J Transplant 2003; 3: 599-605. (Pubitemid 36612843)
6. Torrealba JR, Samaniego M, Pascual J, et al,. C4d-positive interacinar capillaries correlates with donor-specific antibody-mediated rejection in pancreas allografts. Transplantation 2008; 86: 1849-1856.
7. Troxell ML, Koslin DB, Norman D, et al,. Pancreas allograft rejection: Analysis of concurrent renal allograft biopsies and posttherapy follow-up biopsies. Transplantation 2010; 90: 75-84.
8. Drachenberg CB, Papadimitriou JC, Klassen DK, et al,. Evaluation of pancreas transplant needle biopsy: Reproducibility and revision of histologic grading system. Transplantation 1997; 63: 1579-1586. (Pubitemid 27265497)
9. Drachenberg CB, Odorico J, Demetris AJ, et al,. Banff schema for grading pancreas allograft rejection: Working proposal by a multi-disciplinary international consensus panel. Am J Transplant 2008; 8: 1237-1249. (Pubitemid 351763668)
10. Waki K, Terasaki PI, Kadowaki T,. Long term pancreas allograft survival in simultaneous pancreas kidney transplantation by era: UNOS registry analysis. Diabetes Care 2010; 33: 1789-1791.
11. Pascual J, Samaniego MD, Torrealba JR, et al,. Antibody-mediated rejection of the kidney after simultaneous pancreas-kidney transplantation. J Am Soc Nephrol 2008; 19: 812-824.
12. de Kort H, Munivenkatappa RB, Berger SP, et al,. Pancreas allograft biopsies with positive C4d staining and anti-donor antibodies related to worse outcome for patients. Am J Transplant 2010; 10: 1660-1667.
13. Melcher ML, Olson JL, Baxter-Lowe LA, et al,. Antibody-mediated rejection of a pancreas allograft. Am J Transplant 2006; 6: 423-428. (Pubitemid 43382182)
14. Munivenkatappa RB, Philosophe B, Papadimitriou JC, et al,. Interacinar c4d staining in pancreas allografts. Transplantation 2009; 88: 145-146.
15. Rangel EB, Malheiros DM, de Castro MC, et al,. Antibody-mediated rejection (AMR) after pancreas and pancreas-kidney transplantation. Transpl Int 2010; 23: 602-610.
16. Colvin RB,. Dimensions of antibody-mediated rejection. Am J Transplant 2010; 10: 1509-1510.
17. Colvin RB,. Antibody-mediated renal allograft rejection: Diagnosis and pathogenesis. J Am Soc Nephrol 2007; 18: 1046-1056. (Pubitemid 46536891)
18. Gaber LW,. Pancreas allograft biopsies in the management of pancreas transplant recipients: Histopathologic review and clinical correlations. Arch Pathol Lab Med 2007; 131: 1192-1199. (Pubitemid 47257631)
19. Fabio V, Daniele F, Monica DD, et al,. Pancreas rejection after pandemic influenzavirus A(H(1) N(1)) vaccination or infection: A report of two cases. Transpl Int 2011; 24: e28-e29.
20. Zanone MM, Favaro E, Quadri R, et al,. Association of cytomegalovirus infections with recurrence of humoral and cellular autoimmunity to islet autoantigens and of type 1 diabetes in a pancreas transplanted patient. Transpl Int 2010; 23: 333-337.
21. Einecke G, Sis B, Reeve J, et al,. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009; 9: 2520-2531.
22. Papadimitriou JC, Drachenberg CB, Munivenkatappa R, et al,. Glomerular inflammation in renal allografts biopsies after the first year: Cell types and relationship with antibody-mediated rejection and graft outcome. Transplantation 2010; 90: 1478-1485.
23. Everly MJ, Rebellato LM, Ozawa M, et al,. Beyond histology: Lowering human leukocyte antigen antibody to improve renal allograft survival in acute rejection. Transplantation 2010; 89: 962-967.
24. Terasaki PI., The review by Kwun and Knechtle-"can it B?" -asks whether B cells are responsible for chronic rejection of transplants. Transplantation 2009; 88; 978-979.
25. Porcheray F, DeVito J, Yeap BY, et al,. Chronic humoral rejection of human kidney allografts associates with broad autoantibody responses. Transplantation 2010; 89: 1239-1246.
26. Pelletier RP, Hennessy PK, Adams PW, et al,. Clinical significance of MHC-reactive alloantibodies that develop after kidney or kidney-pancreas transplantation. Am J Transplant 2002; 2: 134-141. (Pubitemid 36306792)
27. Daar AS, Fuggle SV, Fabre JW, et al,. The detailed distribution of MHC Class II antigens in normal human organs. Transplantation 1984; 38: 293-298. (Pubitemid 14035182)
28. Daar AS, Fuggle SV, Fabre JW, et al,. The detailed distribution of HLA-A, B, C antigens in normal human organs. Transplantation 1984; 38: 287-292. (Pubitemid 14035181)
29. Fleming KA, McMichael A, Morton JA, et al,. Distribution of HLA class 1 antigens in normal human tissue and in mammary cancer. J Clin Pathol 1981; 34: 779-784. (Pubitemid 11040321)
30. Jackson AM, Connolly JE, Matsumoto S, et al,. Evidence for induced expression of HLA Class II on human islets: Possible mechanism for HLA sensitization in transplant recipients. Transplantation 2009; 87: 500-506.
31. Pavlovic D, van de Winkel M, van der Auwera B, et al,. Effect of interferon-gamma and glucose on major histocompatibility complex class I and class II expression by pancreatic beta- and non-beta-cells. J Clin Endocrinol Metab 1997; 82: 2329-2336. (Pubitemid 27287608)
32. Pujol-Borrell R, Todd I, Doshi M, Gray D, et al,. Differential expression and regulation of MHC products in the endocrine and exocrine cells of the human pancreas. Clin Exp Immunol 1986; 65: 128-139. (Pubitemid 16092893)
33. Steiniger B, Klempnauer J, Wonigeit K,. Altered distribution of class I and class II MHC antigens during acute pancreas allograft rejection in the rat. Transplantation 1985; 40: 234-239. (Pubitemid 15023178)
34. Foulis AK, Farquharson MA, Hardman R,. Aberrant expression of class II major histocompatibility complex molecules by B cells and hyperexpression of class I major histocompatibility complex molecules by insulin containing islets in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1987; 30: 333-343. (Pubitemid 17083703)
35. Gaston RS, Cecka JM, Kasiske BL, et al,. Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplantation 2010; 90: 68-74.
36. Howell WM, Harmer A, Briggs D, et al,. British Society for Histocompatibility & Immunogenetics and British Transplantation Society guidelines for the detection and characterisation of clinically relevant antibodies in allotransplantation. Int J Immunogenet 2010; 37: 435-437.
37. Zeevi A, Lunz JG, 3rd, Shapiro R, et al,. Emerging role of donor-specific anti-human leukocyte antigen antibody determination for clinical management after solid organ transplantation. Hum Immunol 2009; 70: 645-650.
38. Leffell MS, Zachary AA,. Antiallograft antibodies: Relevance, detection, and monitoring. Curr Opin Organ Transplant 2010; 15: 2-7.
39. Zou Y, Stastny P, Susal C, et al,. Antibodies against MICA antigens and kidney-transplant rejection. N Engl J Med 2007; 357: 1293-1300. (Pubitemid 47481451)
40. Feucht HE, Opelz G,. The humoral immune response towards HLA class II determinants in renal transplantation. Kidney Int 1996; 50: 1464-1475. (Pubitemid 26364250)
41. Minami K, Murata K, Lee CY, et al,. C4d deposition and clearance in cardiac transplants correlates with alloantibody levels and rejection in rats. Am J Transplant 2006; 6 (5 Pt 1): 923-932. (Pubitemid 44356642)
42. Halloran PF, de Freitas DG, Einecke G, et al. The molecular phenotype of kidney transplants. Am J Transplant 2010; 10: 2215-2222.
43. Sis B, Halloran PF,. Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection. Curr Opin Organ Transplant 2010; 15: 42-48.
44. Loupy A, Hill GS, Suberbielle C, et al,. Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA). Am J Transplant 2011; 11: 56-65.
45. Solez K, Colvin RB, Racusen LC, et al,. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008; 8: 753-760. (Pubitemid 351347767)
46. Miller DV, Roden AC, Gamez JD, et al,. Detection of C4d deposition in cardiac allografts: A comparative study of immunofluorescence and immunoperoxidase methods. Arch Pathol Lab Med 2010; 134: 1679-1684.
47. Haririan A, Kiangkitiwan B, Kukuruga D, et al,. The impact of c4d pattern and donor-specific antibody on graft survival in recipients requiring indication renal allograft biopsy. Am J Transplant 2009; 9: 2758-2767.
48. Troppmann C, Gruessner AC, Benedetti E, et al,. Vascular graft thrombosis after pancreatic transplantation: Univariate and multivariate operative and nonoperative risk factor analysis. J Am Coll Surg 1996; 182: 285-316. (Pubitemid 26105962)
49. Sibley RK,. Pancreas transplantation. In:, Sale GE, ed. The pathology of organ transplantation. Boston: Butterworth Publishers, 1990: 179-215.
50. Hawthorne WJ, Griffin AD, Lau H, et al,. Experimental hyperacute rejection in pancreas allotransplants. Transplantation 1996; 62: 324-329. (Pubitemid 26277336)
51. Heilman RL, Chakkera H, Mazur M, et al,. Outcomes of simultaneous kidney-pancreas transplantation with positive cross-match. Transplant Proc 2009; 41: 303-306.
52. Khwaja K, Wijkstrom M, Gruessner A, et al,. Pancreas transplantation in crossmatch-positive recipients. Clin Transplant 2003; 17: 242-248. (Pubitemid 36748472)
53. Litmathe J, Bektas H, Jorns A, et al,. Time frame of pancreas allograft rejection: An immunogenetic analysis in MHC-disparate, presensitized inbred rat strains. Transplant Proc 2003; 35: 3147-3152. (Pubitemid 38102152)
54. Pascual J, Pirsch JD, Odorico JS, et al,. Alemtuzumab induction and antibody-mediated kidney rejection after simultaneous pancreas-kidney transplantation. Transplantation 2009; 87: 125-132.
55. Prikis M, Norman D, Rayhill S, et al,. Preserved endocrine function in a pancreas transplant recipient with pancreatic panniculitis and antibody-mediated rejection. Am J Transplant 2010; 10: 2717-2722.
56. Gibson IW, Gwinner W, Brocker V, et al,. Peritubular capillaritis in renal allografts: Prevalence, scoring system, reproducibility and clinicopathological correlates. Am J Transplant 2008; 8: 819-825. (Pubitemid 351347749)
57. Liptak P, Kemeny E, Morvay Z, et al,. Peritubular capillary damage in acute humoral rejection: An ultrastructural study on human renal allografts. Am J Transplant 2005; 5: 2870-2876. (Pubitemid 43923946)
58. Carbajal R, Karam G, Renaudin K, et al,. Specific humoral rejection of a pancreas allograft in a recipient of pancreas after kidney transplantation. Nephrol Dial Transplant 2007; 22: 942-944. (Pubitemid 46351714)
59. Hirohashi T, Uehara S, Chase CM, et al,. Complement independent antibody-mediated endarteritis and transplant arteriopathy in mice. Am J Transplant 2010; 10: 510-517.
60. Shimizu T, Ishida H, Shirakawa H, et al,. Clinicopathological analysis of acute vascular rejection cases after renal transplantation. Clin Transplant 2010; 24 (Suppl 22): 22-26.
61. Sis B, Einecke G, Chang J, et al,. Cluster analysis of lesions in nonselected kidney transplant biopsies: Microcirculation changes, tubulointerstitial inflammation and scarring. Am J Transplant 2010; 10: 421-430.
62. Vendrame F, Pileggi A, Laughlin E, et al,. Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells. Diabetes 2010; 59: 947-957.
63. Tyden G, Reinholt FP, Sundkvist G, et al,. Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic grafts. N Engl J Med 1996; 335: 860-863. (Pubitemid 26304068)
64. Cai K, Qi D, Wang O, et al,. TNF-alpha acutely upregulates amylin expression in murine pancreatic beta cells. Diabetologia 2011; 54: 617-626.
65. Jaikaran ET, Clark A., Islet amyloid and type 2 diabetes: From molecular misfolding to islet pathophysiology. Biochim Biophys Acta 2001; 1537: 179-203. (Pubitemid 33139801)
66. Sis B, Mengel M, Haas M, et al,. Banff '09 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010; 10: 464-471.
67. Halloran PF, de Freitas DG, Einecke G, et al. An integrated view of molecular changes, histopathology and outcomes in kidney transplants. Am J Transplant 2010; 10: 2223-2230.
68. Sis B, Jhangri GS, Bunnag S, et al,. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 2009; 9: 2312-2323.
69. Stegall MD, Gloor JM,. Deciphering antibody-mediated rejection: New insights into mechanisms and treatment. Curr Opin Organ Transplant 2010; 15: 8-10.
70. Mengel M, Sis B, Halloran PF,. SWOT analysis of Banff: Strengths, weaknesses, opportunities and threats of the international Banff consensus process and classification system for renal allograft pathology. Am J Transplant 2007; 7: 2221-2226. (Pubitemid 47347849)